|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Mayo Clinic National Institutes of Health (NIH) Oxalosis and Hyperoxaluria Foundation (OHF) |
|---|---|
| Information provided by: | Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT00588562 |
Purpose
The purpose of this study is to collect medical information from a large number of patients in many areas of the world with Primary Hyperoxaluria (PH). This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias and learn better ways of caring for patients with this disease.
| Condition | Intervention |
|---|---|
|
Primary Hyperoxaluria |
Other: Registry |
| Study Type: | Observational |
| Official Title: | International Registry for Hereditary Calcium Stone Diseases - An Outside Assisted Center Protocol for the Addition of New Patients Into the Existing Registry (IRB#1605-03). |
| Estimated Enrollment: | 400 |
| Study Start Date: | July 2003 |
| Estimated Study Completion Date: | July 2010 |
| Estimated Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
This study involves the collection of medical information to create a computer database or registry for patients with PH. The information will be entered into the registry by your physician or health care provider. The computer web site for the registry is secure and protected by a required password. Some information which will be entered may include your age at first symptoms of PH, lab values, kidney function and the progress of your health over time. Information for an individual patient can only be viewed by the appropriate physician or staff. Once the information is entered into the registry, you will only be identified by a code number.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Individuals with Primary Hyperoxaluria
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Susan R. Rogers | 507-266-9391 | rogers.susan@mayo.edu |
| Contact: Mayo Clinic Hyperoxaluria Center | 1-800-270-4637 | hyperoxaluriacenter@mayo.edu |
| United States, Minnesota | |
| Mayo Clinic | Recruiting |
| Rochester, Minnesota, United States, 55905 | |
| Principal Investigator: John Lieske, MD | |
More Information
| Responsible Party: | Mayo Clinic ( Dr. John Lieske ) |
| Study ID Numbers: | 07-003476, DK73354-03 |
| Study First Received: | December 27, 2007 |
| Last Updated: | January 30, 2008 |
| ClinicalTrials.gov Identifier: | NCT00588562 |
| Health Authority: | United States: Federal Government; United States: Institutional Review Board |
|
PH PH1 PH2 PH3 PHI |
PHII PHIII Primary Hyperoxaluria Primary Oxalosis Hyperoxaluria |
|
Calcium, Dietary Metabolism, Inborn Errors Metabolic Diseases Hyperoxaluria, Primary Genetic Diseases, Inborn Urologic Diseases |
Hyperoxaluria Kidney Diseases Metabolic disorder Calculi Oxalosis |
|
Carbohydrate Metabolism, Inborn Errors |
